Feb 27

Careers at Thermo Fisher Scientific Thermo Fisher Scientific jobs

Content

  • Research & Development
  • Green Solutions

    • PayID casino

    In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

    It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

    This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

    In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

    Grab Deals Before They're Gone

    In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

    In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

    Green Solutions

    In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

    The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

    Feb 27

    Careers at Thermo Fisher Scientific Thermo Fisher Scientific jobs

    Content

  • Research & Development
  • Green Solutions

    • PayID casino

    In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

    It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

    This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

    In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

    Grab Deals Before They're Gone

    In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

    In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

    Green Solutions

    In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

    The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

    Feb 27

    Careers at Thermo Fisher Scientific Thermo Fisher Scientific jobs

    Content

  • Research & Development
  • Green Solutions

    • PayID casino

    In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

    It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

    This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

    In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

    Grab Deals Before They're Gone

    In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

    In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

    Green Solutions

    In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

    The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

    Feb 27

    Careers at Thermo Fisher Scientific Thermo Fisher Scientific jobs

    Content

  • Research & Development
  • Green Solutions

    • PayID casino

    In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

    It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

    This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

    In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

    Grab Deals Before They're Gone

    In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

    In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

    Green Solutions

    In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

    The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

    Feb 27

    Careers at Thermo Fisher Scientific Thermo Fisher Scientific jobs

    Content

  • Research & Development
  • Green Solutions

    • PayID casino

    In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

    It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

    This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

    In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

    Grab Deals Before They're Gone

    In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

    In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

    Green Solutions

    In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

    The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

    Jan 16

    Intent and Freeing Beliefs

    The intent is a one-pointedness in our beliefs. Intent clarifies and energizes beliefs, giving them power and direction. The clear intent is one of the most powerful forces available to us.

             When you choose a new belief, be forceful; fill that belief with energy. By fully accepting that our beliefs create our reality, we place into motion our committed intent. Barriers that have been blocking our movements begin to fall away as we gain confidence in our natural power to materialize our beliefs into reality.

             This has always been happening. It’s just that we have not recognized or taken responsibility for this naturally unavoidable condition of existence. Taking responsibility for this with conscious awareness brings new freedom into our lives. Solutions become evident.  Daily experience reveals answers to old problems that were always present but seldom seen. Suddenly, new directions, disguised as unnoticed choices, an opportunity where previously none was detected.

             Your focus will direct your energy. Be aggressive. Birth is aggressive, life is aggressive, the unfolding of a flower is aggressive, and a thunderstorm is aggressive. These are all powerful expressions of intent. We have that same power available to us at all times – use it!  If you don’t choose your beliefs, they will choose you. It is easier to choose your beliefs than to be thrown from one state of mind to another by unexamined and unknown ideas.

    Jan 16

    The Freedom of Beliefs

    Remember, beliefs are changeable just like sweaters or pants;  what you have for dinner, words you place on paper, paint in a picture, notes in a melody, or whom you spend the day with.

             Beliefs are choices. We choose them, or, if we are unaware of them, they often choose us. Either way, they are creating our everyday reality. Whether you believe this or not, it is still true.

             In order to be responsible and have freedom and choice in our lives, it is necessary to take responsibility for our beliefs. To have responsibility for our beliefs, we must be “able to respond.”  Respond to limiting beliefs by changing them and to life-promoting beliefs by encouraging them.  To do this, we must first believe that beliefs are changeable.

    Core Beliefs

    Core beliefs or core concepts about our everyday reality are very powerful indeed.  Their particular and unique power derives from their obvious nature. They are so a part of our daily perception that we mistake them for REALITY.  We don’t see them as beliefs, which renders them immutable and unchangeable. This causes us to lose our sense of individual power and free will, leading to hopelessness and helplessness. We believe we are “victims” of “reality” and cease to recognize our power to change our beliefs.

             Look around you. All that you see is not reality.  It is your “reality” through the focus of your personal and culturally accepted beliefs.  Change those beliefs and you will change your “reality.”  The more thoroughly you accept these new ideas, the greater the change in your experience.  You are the creator of your experience. The artist of your own life. Pick your colors well and plan the picture most pleasing to you. It’s your picture and the quality of every painting is in the eye of the beholder. Don’t trade your free will for the likes and dislikes of another. It is the very diversity of opinion that gives life variety and interest.  If we all lived according to the views of others, there would be no excitement, only the sameness of these opinions and ideas.  The purpose of life would be lost in the beliefs of others.

    Jan 12

    What is Belief Therapy?

    To understand Belief Therapy, it is necessary to understand that the primary, most revolutionary, and perhaps remarkable tenet of Belief Therapy is also its most simple. It is that: there is nothing wrong with us.

    We are already OK. There is nothing to fix and there never was. Oddly enough, our attempts to fix ourselves often lead to our dis-ease.

    The “problem” is our belief in our brokenness. This belief causes compulsive, self, and/or other destructive behavior, which then creates “evidence” of our brokenness, continuing the self-fulfilling prophecy of desperation and limitation.

    Once the belief in our brokenness takes hold, our options become limited. We either attempt to fix what was never broken, which creates distress, dis-ease, and obsessive/compulsive behavior; or, we give up trying to fix ourselves, accept the belief in our brokenness or “badness” and subsequently act in limiting and destructive ways. Either direction leads to a path that lacks the quality and joy that is our birthright. By adopting the tenets of Belief Therapy and recognizing our inherent and pre-existing “goodness,” we lose these limiting and compulsive behaviors and recognize our freedom to choose a life of quality.

    If you want to learn more…

    Jan 12

    The Sinful Self

    Freeing ourselves from obsessive introspection allows for participatory relationships with others. We are now free to explore the moment. Free to explore the boundless, aware, energy around us. This may sound mystical or esoteric, but it is the most practical, concrete, and pragmatic of all understandings. Through this awareness, we fully participate in the reality of our lives.

            What is impractical is continuing to obsessively examine our ideas of others’ perceptions about us. At these times we are only in touch with our own imagination. In essence, with nothing, nothing, no reality. Just our autistic thoughts about what we think they think about us. We then imagine what they imagine this must mean. I’ll tell you what it means. It means nothing! Nothing. No reality. We create knot after knot in our daily lives, all based upon a mirage.

            Ironically, oftentimes we create the opposite of the impression we want. The attempt to control others’ impressions and perceptions of us, often makes us so uptight, anxious, and insecure that this is what they see. We have squeezed ourselves out of the natural flowing shape others often find desirable, and once again, our solution has become our problem. One self-fulfilling prophecy after another, like snowballs rolling the wrong way down the hill.

            Learning to accept and believe in ourselves allows for the natural expression of our being, which we find pleasing, and oddly enough so do others. Opening our hearts to ourselves, once again we come full circle back to the excitement, pleasure, and challenges of everyday life. How important are things when we have ourselves? How important are images when we have reality? By believing in our wholeness, we cease our obsessive strivings, lose our attachment to image and allow ourselves to see. What we see, once again, is that most precious event, our day-to-day life.

    if you want to learn more...

    Jan 12

    Feeling Trapped

    When you are feeling trapped, take time to look within yourself. Observe the situations and circumstances of your everyday life. Discover the choices you have been making leading to these circumstances. Imagine the beliefs that are guiding those types of choices. Look backward into the past and take responsibility for your choices that have created your present. Recognize that you have full freedom at this moment to begin to make different choices and to create different present moments; ones more to your liking, filled with quality and freedom.

             See what choices are available to you right now. Look carefully, because choices, when you are not used to looking for them, can seem to be invisible. They appear not to exist, but in fact, they are there. Start with very simple and obvious choices. “What can I choose; what are my options? Could I choose this instead of that? What might happen if I chose that instead of this?” Then take responsibility for both your past and present choices. Visualize the future you desire, imagine the choices necessary to create that future, and take responsibility for beginning that process now. Stop being a victim.

             The simple truth is, you were born free; you have free will and choices available to you now. You are responsible for those choices and the circumstances arising from them. You choose your life. Look closely into your past, present, and future. Examine your beliefs, discover your choices, and create your reality.